JP2009520695A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520695A5
JP2009520695A5 JP2008545125A JP2008545125A JP2009520695A5 JP 2009520695 A5 JP2009520695 A5 JP 2009520695A5 JP 2008545125 A JP2008545125 A JP 2008545125A JP 2008545125 A JP2008545125 A JP 2008545125A JP 2009520695 A5 JP2009520695 A5 JP 2009520695A5
Authority
JP
Japan
Prior art keywords
compound according
group
solvate
hydrate
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008545125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009520695A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/003549 external-priority patent/WO2007069020A2/en
Publication of JP2009520695A publication Critical patent/JP2009520695A/ja
Publication of JP2009520695A5 publication Critical patent/JP2009520695A5/ja
Pending legal-status Critical Current

Links

JP2008545125A 2005-12-15 2006-12-04 抗菌活性を有するn−ヒドロキシアミド誘導体 Pending JP2009520695A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75060005P 2005-12-15 2005-12-15
PCT/IB2006/003549 WO2007069020A2 (en) 2005-12-15 2006-12-04 N-hydroxyamide derivatives possessing antibacterial activity

Publications (2)

Publication Number Publication Date
JP2009520695A JP2009520695A (ja) 2009-05-28
JP2009520695A5 true JP2009520695A5 (US07794700-20100914-C00152.png) 2010-01-28

Family

ID=38163279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008545125A Pending JP2009520695A (ja) 2005-12-15 2006-12-04 抗菌活性を有するn−ヒドロキシアミド誘導体

Country Status (5)

Country Link
US (1) US8088804B2 (US07794700-20100914-C00152.png)
EP (2) EP1963262A2 (US07794700-20100914-C00152.png)
JP (1) JP2009520695A (US07794700-20100914-C00152.png)
CA (1) CA2634005C (US07794700-20100914-C00152.png)
WO (1) WO2007069020A2 (US07794700-20100914-C00152.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539744A4 (en) 2002-07-11 2007-06-06 Vicuron Pharm Inc N-HYDROXYAMIDE DERIVATIVES WITH ANTIBACTERIAL EFFECT
EP2662353A3 (en) 2007-06-12 2014-04-02 Achaogen, Inc. Antibacterial agents
WO2009105140A2 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
AU2009276343A1 (en) * 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
CA2735929C (en) 2008-09-19 2013-12-17 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
MY159355A (en) * 2008-11-19 2016-12-30 Pola Chem Ind Inc Anti-wrinkle agents
EP2488489A2 (en) * 2009-10-13 2012-08-22 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
EP2512474B1 (en) * 2009-12-16 2014-11-05 Pfizer Inc N-linked hydroxamic acid derivatives useful as antibacterial agents
TR201908891T4 (tr) 2010-04-20 2019-07-22 Fujifilm Toyama Chemical Co Ltd Yeni̇ hi̇droksami̇k asi̇t türevi̇
ES2626457T3 (es) * 2011-03-07 2017-07-25 Pfizer Inc. Derivados de fluoro-piridinona útiles como agentes antibacterianos
SG193458A1 (en) * 2011-04-08 2013-10-30 Pfizer Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
KR20130140868A (ko) 2011-04-08 2013-12-24 화이자 인코포레이티드 항세균제로서 유용한 이속사졸 유도체
JP6006609B2 (ja) * 2011-10-19 2016-10-12 大正製薬株式会社 新規なヒドロキサム酸誘導体を含有する医薬
WO2013170165A1 (en) 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
DK2975022T3 (da) 2013-03-15 2019-07-15 Fujifilm Toyama Chemical Co Ltd Hidtil ukendt hydroxaminsyrederivat eller salt deraf
EP2883876A1 (en) 2013-12-16 2015-06-17 Actelion Pharmaceuticals Ltd. Stereoselective synthesis of substituted pyrrolidines
JPWO2016039433A1 (ja) 2014-09-12 2017-06-22 富山化学工業株式会社 新規なヒドロキサム酸誘導体またはその塩を含有する医薬組成物
KR20170047390A (ko) 2014-09-12 2017-05-04 토야마 케미칼 컴퍼니 리미티드 신규 히드록삼산 유도체 및 항균성 물질을 조합하여 사용하는 방법
CN108569991A (zh) * 2018-05-31 2018-09-25 常州制药厂有限公司 一种抗丙肝病毒药物关键中间体的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077998A (en) * 1975-10-28 1978-03-07 Morton-Norwich Products, Inc. Phthaloyl amino acid hydroxamic acids
PT850215E (pt) * 1995-07-26 2001-03-30 Pfizer Derivados de acidos n-(aroil)glicina-hidroxamicos e compostos relacionados
US6693123B2 (en) * 1995-11-06 2004-02-17 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
DK0873123T3 (da) * 1995-11-06 2003-08-04 Univ Pittsburgh Inhibitorer af protein-isoprenyltransferaser
US5925659A (en) 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
IL134273A0 (en) * 1997-07-31 2001-04-30 Procter & Gamble Acyclic metalloprotease inhibitors
US6784173B2 (en) * 2001-06-15 2004-08-31 Hoffmann-La Roche Inc. Aromatic dicarboxylic acid derivatives
EP1539744A4 (en) 2002-07-11 2007-06-06 Vicuron Pharm Inc N-HYDROXYAMIDE DERIVATIVES WITH ANTIBACTERIAL EFFECT
KR101145252B1 (ko) 2003-01-08 2012-05-24 유니버시티 오브 워싱톤 항균제
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
DE10348023A1 (de) * 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
WO2006013209A2 (en) 2004-08-02 2006-02-09 Genmedica Therapeutics Sl Compounds for inhibiting copper-containing amine oxidases and uses thereof
WO2006040646A1 (en) 2004-10-14 2006-04-20 Pfizer, Inc. Benzimidazole or indole amides as inhibitors of pin1
US20100152188A1 (en) 2005-08-05 2010-06-17 Akella Satya Surya Visweswara Srinivas Novel Heterocyclic Compounds

Similar Documents

Publication Publication Date Title
JP2009520695A5 (US07794700-20100914-C00152.png)
JP2010527913A5 (US07794700-20100914-C00152.png)
JP2010530881A5 (US07794700-20100914-C00152.png)
WO2006039668B1 (en) 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
JP2006505543A5 (US07794700-20100914-C00152.png)
JP2005523922A5 (US07794700-20100914-C00152.png)
JP2015537020A5 (US07794700-20100914-C00152.png)
JP2013503846A5 (US07794700-20100914-C00152.png)
JP2010530372A5 (US07794700-20100914-C00152.png)
WO2005084192A3 (en) Novel 2’-c-methyl nucleoside derivatives
JP2008510828A5 (US07794700-20100914-C00152.png)
WO2004062601A3 (en) Antibacterial agents
JP2009500423A5 (US07794700-20100914-C00152.png)
JP2009536660A5 (US07794700-20100914-C00152.png)
JP2009510128A5 (US07794700-20100914-C00152.png)
JP2003519676A5 (US07794700-20100914-C00152.png)
CA2634005A1 (en) N-hydroxyamide derivatives possessing antibacterial activity
JP2009511508A5 (US07794700-20100914-C00152.png)
JP2013507425A5 (US07794700-20100914-C00152.png)
JP2006514012A5 (US07794700-20100914-C00152.png)
WO2008005519A3 (en) Novel pyridazine compound and use thereof
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
JP2005053931A5 (US07794700-20100914-C00152.png)
JP2007534702A5 (US07794700-20100914-C00152.png)
JP2013510178A5 (US07794700-20100914-C00152.png)